| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,146 |
3,395 |
$179K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,478 |
3,633 |
$176K |
| G0511 |
Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month |
2,007 |
1,795 |
$27K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
221 |
205 |
$16K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,150 |
1,543 |
$12K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
283 |
229 |
$11K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
210 |
209 |
$5K |
| 99490 |
Ccm add 20min |
155 |
155 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
103 |
96 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
2,029 |
1,732 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
110 |
101 |
$867.52 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
93 |
81 |
$685.86 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
563 |
471 |
$499.37 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,056 |
827 |
$170.70 |
| 90674 |
|
22 |
18 |
$24.00 |
| 81002 |
|
16 |
12 |
$15.65 |
| G0008 |
Administration of influenza virus vaccine |
21 |
17 |
$0.00 |